• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
KUANG Zheng,QIN Chao,YANG Lei,YIN Lifang,HAN Xiaopeng.Research progress on nanomedicine overcoming tumor multidrug resistance[J].Journal Of Pharmaceutical Research,2022,41(10):667-672,696[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2486times   Download 2896次 QR Code for this article
Scan with your phone!
纳米制剂克服肿瘤多药耐药的研究进展
匡正,秦超,杨磊,尹莉芳,韩晓鹏
Font:Larger+|Default|Smaller-
(中国药科大学药学院,江苏 南京 211198)
摘要:
多药耐药性是肿瘤治疗的重要障碍。靶向性、协同载药能力等功能使纳米制剂成为克服肿瘤多药耐药的理想载体。本文首先介绍了多药耐药性的主要产生机制,然后着重介绍了基于抑制外排、诱导细胞程序性死亡的多功能纳米制剂,用于逆转肿瘤多药耐药性的研究进展,以期为耐药性肿瘤治疗提供思路和方法。
关键词:  纳米制剂  肿瘤  多药耐药
DOI:10.13506/j.cnki.jpr.2022.10.008
基金项目:国家科技重大专项“重大新药创制”项目(No.2017ZX09101001-004)
Research progress on nanomedicine overcoming tumor multidrug resistance
KUANG Zheng,QIN Chao,YANG Lei,YIN Lifang,HAN Xiaopeng
(School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China)
Abstract:
For cancer treatment, multidrug resistance (MDR) is an important obstacle. The excellent functions of nanomedicine, such as targeting and co-delivery of drugs, make it a good carrier of overcoming MDR. This paper introduces main mechanisms of MDR, focusing on the design of nanomedicine to overcome MDR with the guidance of inhibiting efflux, inducing programmed cell death,and reversing multidrug resistance by targeting tumor micro-environment. This paper provides reference for the treatment of drug-resistant tumors.
Key words:  Nanomedicine  Tumor  Multidrug resistance
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.